Since the discovery of cell-free fetal DNA (cffDNA) in maternal plasma, diagnostic non-invasive prenatal methods have been developed. As far as Y-chromosome identification, this might be important for therapeutic intervention on sex-associated pathologies such as Duchenne muscular dystrophy, hemophilia and congenital adrenal hyperplasia. Surface plasmon resonance (SPR)-based biosensors might be useful for these studies, because they allow to monitor the molecular interactions in real-time providing qualitative and quantitative information, through kinetics, affinity and concentration analyses. In this study BiacoreTM X100 has been applied to identify the Y-chromosome in cffDNA obtained from plasma samples of 26 pregnant women at different gestational ages, analysing the binding between SRY-PCR products and an SRY-specific probe immobilized on the sensor chip. The results suggest that there is a statistically significant difference between samples collected by pregnancies carrying male or female fetus. Moreover cffDNA, obtained at early gestational ages (6th-7th week) and not detectable by conventional quantitative real-time PCR, can be discriminated with high accuracy and reliability using SPR-based biosensors (Breveglieri G et. al, Prenatal Diagnosis 2016, 36, 353–361) and pre-amplification steps. In conclusion these results should be considered as the basis of future developments for more extensive diagnostic trials.

SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome

BREVEGLIERI, Giulia;COSENZA, Lucia Carmela;PELLEGATTI, Patrizia;GUERRA, Giovanni;SALVATORI, Francesca;D'AVERSA, Elisabetta;FINOTTI, Alessia;GAMBARI, Roberto;BORGATTI, Monica
2016

Abstract

Since the discovery of cell-free fetal DNA (cffDNA) in maternal plasma, diagnostic non-invasive prenatal methods have been developed. As far as Y-chromosome identification, this might be important for therapeutic intervention on sex-associated pathologies such as Duchenne muscular dystrophy, hemophilia and congenital adrenal hyperplasia. Surface plasmon resonance (SPR)-based biosensors might be useful for these studies, because they allow to monitor the molecular interactions in real-time providing qualitative and quantitative information, through kinetics, affinity and concentration analyses. In this study BiacoreTM X100 has been applied to identify the Y-chromosome in cffDNA obtained from plasma samples of 26 pregnant women at different gestational ages, analysing the binding between SRY-PCR products and an SRY-specific probe immobilized on the sensor chip. The results suggest that there is a statistically significant difference between samples collected by pregnancies carrying male or female fetus. Moreover cffDNA, obtained at early gestational ages (6th-7th week) and not detectable by conventional quantitative real-time PCR, can be discriminated with high accuracy and reliability using SPR-based biosensors (Breveglieri G et. al, Prenatal Diagnosis 2016, 36, 353–361) and pre-amplification steps. In conclusion these results should be considered as the basis of future developments for more extensive diagnostic trials.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11392/2369102
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact